147 related articles for article (PubMed ID: 33845596)
1. Boronic acid/boronate prodrugs for cancer treatment: current status and perspectives.
Maslah H; Pethe S; Labruère R
Future Med Chem; 2021 May; 13(10):859-861. PubMed ID: 33845596
[No Abstract] [Full Text] [Related]
2. Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment.
Maslah H; Skarbek C; Pethe S; Labruère R
Eur J Med Chem; 2020 Dec; 207():112670. PubMed ID: 32858470
[TBL] [Abstract][Full Text] [Related]
3. ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.
Peng X; Gandhi V
Ther Deliv; 2012 Jul; 3(7):823-33. PubMed ID: 22900465
[TBL] [Abstract][Full Text] [Related]
4. Aminoferrocene-based prodrugs activated by reactive oxygen species.
Hagen H; Marzenell P; Jentzsch E; Wenz F; Veldwijk MR; Mokhir A
J Med Chem; 2012 Jan; 55(2):924-34. PubMed ID: 22185340
[TBL] [Abstract][Full Text] [Related]
5. Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs.
Daum S; Reshetnikov MSV; Sisa M; Dumych T; Lootsik MD; Bilyy R; Bila E; Janko C; Alexiou C; Herrmann M; Sellner L; Mokhir A
Angew Chem Int Ed Engl; 2017 Dec; 56(49):15545-15549. PubMed ID: 28994179
[TBL] [Abstract][Full Text] [Related]
6. ROS-inducible DNA cross-linking agent as a new anticancer prodrug building block.
Cao S; Wang Y; Peng X
Chemistry; 2012 Mar; 18(13):3850-4. PubMed ID: 22378607
[No Abstract] [Full Text] [Related]
7. Photoactivation of Boronic Acid Prodrugs via a Phenyl Radical Mechanism: Iridium(III) Anticancer Complex as an Example.
Liu M; Luo Y; Yan J; Xiong X; Xing X; Kim JS; Zou T
J Am Chem Soc; 2023 May; 145(18):10082-10091. PubMed ID: 37098902
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic iminoboronate-based polymersomes with a Cu(ii)-mediated Fenton reaction-enhanced ROS-response.
Cheng R; Li G; Fan L; Jiang J; Zhao Y
Chem Commun (Camb); 2020 Oct; 56(81):12246-12249. PubMed ID: 32929426
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species (ROS) inducible DNA cross-linking agents and their effect on cancer cells and normal lymphocytes.
Chen W; Balakrishnan K; Kuang Y; Han Y; Fu M; Gandhi V; Peng X
J Med Chem; 2014 Jun; 57(11):4498-510. PubMed ID: 24801734
[TBL] [Abstract][Full Text] [Related]
10. Identification of Boronic Acid Derivatives as an Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with
Daum S; Toms J; Reshetnikov V; Özkan HG; Hampel F; Maschauer S; Hakimioun A; Beierlein F; Sellner L; Schmitt M; Prante O; Mokhir A
Bioconjug Chem; 2019 Apr; 30(4):1077-1086. PubMed ID: 30768258
[TBL] [Abstract][Full Text] [Related]
11. Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer.
Skarbek C; Serra S; Maslah H; Rascol E; Labruère R
Bioorg Chem; 2019 Oct; 91():103158. PubMed ID: 31376782
[TBL] [Abstract][Full Text] [Related]
12. Molecular imprinted S-nitrosothiols nanoparticles for nitric oxide control release as cancer target chemotherapy.
Liu T; Qiao Z; Wang J; Zhang P; Zhang Z; Guo DS; Yang X
Colloids Surf B Biointerfaces; 2019 Jan; 173():356-365. PubMed ID: 30316082
[TBL] [Abstract][Full Text] [Related]
13. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform.
Huang Y; Zhang W; Xu Y; Zhu S; Wu Y; Chen T; Xiao Y; Lu W; Zhang X; Yu J
Int J Pharm; 2020 Apr; 580():119250. PubMed ID: 32209369
[TBL] [Abstract][Full Text] [Related]
14. ROS-responsive and multifunctional anti-Alzheimer prodrugs: Tacrine-ibuprofen hybrids via a phenyl boronate linker.
Liu Z; Zhang B; Xia S; Fang L; Gou S
Eur J Med Chem; 2021 Feb; 212():112997. PubMed ID: 33189440
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment activated nanoenzyme-based agents for enhanced MRI-guided photothermal therapy in the NIR-II window.
Chen Y; Liu Y; Kuang P; Guo C; Zan J; Xie C; Yin C; Fan Q
Chem Commun (Camb); 2022 Feb; 58(16):2742-2745. PubMed ID: 35119059
[TBL] [Abstract][Full Text] [Related]
16. Injectable Reactive Oxygen Species-Responsive SN38 Prodrug Scaffold with Checkpoint Inhibitors for Combined Chemoimmunotherapy.
Gong Y; Chen M; Tan Y; Shen J; Jin Q; Deng W; Sun J; Wang C; Liu Z; Chen Q
ACS Appl Mater Interfaces; 2020 Nov; 12(45):50248-50259. PubMed ID: 33135879
[TBL] [Abstract][Full Text] [Related]
17. Chemical and biological evaluation of dipeptidyl boronic acid proteasome inhibitors for use in prodrugs and pro-soft drugs targeting solid tumors.
Milo LJ; Lai JH; Wu W; Liu Y; Maw H; Li Y; Jin Z; Shu Y; Poplawski SE; Wu Y; Sanford DG; Sudmeier JL; Bachovchin WW
J Med Chem; 2011 Jul; 54(13):4365-77. PubMed ID: 21634429
[TBL] [Abstract][Full Text] [Related]
18. A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment.
Zhou S; Hu X; Xia R; Liu S; Pei Q; Chen G; Xie Z; Jing X
Angew Chem Int Ed Engl; 2020 Dec; 59(51):23198-23205. PubMed ID: 32852145
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs.
Kuang Y; Balakrishnan K; Gandhi V; Peng X
J Am Chem Soc; 2011 Dec; 133(48):19278-81. PubMed ID: 22035519
[TBL] [Abstract][Full Text] [Related]
20. An Endoplasmic Reticulum Specific Pro-amplifier of Reactive Oxygen Species in Cancer Cells.
Xu HG; Schikora M; Sisa M; Daum S; Klemt I; Janko C; Alexiou C; Bila G; Bilyy R; Gong W; Schmitt M; Sellner L; Mokhir A
Angew Chem Int Ed Engl; 2021 May; 60(20):11158-11162. PubMed ID: 33656236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
